These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 7297496)

  • 1. Identification of a specific inhibitor of nonsuppressible insulin-like activity in a partially purified human serum fraction.
    Herington AC; Kuffer AD
    Endocrinology; 1981 Nov; 109(5):1634-40. PubMed ID: 7297496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of the action of nonsuppressible insulin-like activity on isolated rat fat cells by binding to its carrier protein.
    Zapf J; Schoenle E; Jagars G; Sand I; Grunwald J; Froesch ER
    J Clin Invest; 1979 May; 63(5):1077-84. PubMed ID: 447829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for a biologically active, carrier-bound form of non-suppressible insulin-like activity (NSILA) in human serum.
    Cornell HJ; Herington AC
    Int J Biochem; 1983; 15(4):553-8. PubMed ID: 6852354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Partial purification and characterization of somatomedin from sheep serum.
    Hossner KL; Davis SL; Powell C; Sasser RG
    Endocrinology; 1985 Apr; 116(4):1351-6. PubMed ID: 3971919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentiation between carrier-bound forms of non-suppressible insulin-like activity (NSILA) in serum.
    Cornell HJ; Bistrin M; Herington AC
    Int J Biochem; 1985; 17(9):1003-8. PubMed ID: 4065403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Demonstration of a specific serum carrier protein of nonsuppressible insulin-like activity in vivo.
    Kaufmann U; Zapf J; Torretti B; Froesch ER
    J Clin Endocrinol Metab; 1977 Jan; 44(1):160-6. PubMed ID: 833254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Partial purification of low molecular weight non-suppressible insulin-like activity from human plasma: demonstration of the presence of multiple forms.
    Cockerill PN; Cornell HJ; Herington AC
    J Endocrinol; 1980 May; 85(2):266-77. PubMed ID: 7400715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preferential association of the insulin-like growth factors I and II with metabolically inactive and active carrier-bound complexes in serum.
    Cornell HJ; Enberg G; Herington AC
    Biochem J; 1987 Feb; 241(3):745-50. PubMed ID: 3593220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonsuppressible insulin-like activity of human serum. A potent inhibitor of insulin degradation.
    Kahn CR; Megyesi K; Roth J
    J Clin Invest; 1976 Feb; 57(2):526-9. PubMed ID: 1254732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polypeptides with nonsuppressible insulin-like and cell-growth promoting activities in human serum: isolation, chemical characterization, and some biological properties of forms I and II.
    Rinderknecht E; Humbel RE
    Proc Natl Acad Sci U S A; 1976 Jul; 73(7):2365-9. PubMed ID: 1065887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of serum nonsuppressible insulin-like activity (NSILA) in wound healing. I. Influence of thyroparathyroidectomy on serum NSILA and wound healing in the rat.
    Poffenbarger PL; Haberal MA
    Surgery; 1976 Nov; 80(5):608-16. PubMed ID: 982280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The purification and partial characterization of an insulin-like protein from human serum.
    Poffenbarger PL
    J Clin Invest; 1975 Dec; 56(6):1455-63. PubMed ID: 1202080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amino-terminal sequences of two polypeptides from human serum with nonsuppressible insulin-like and cell-growth-promoting activities: evidence for structural homology with insulin B chain.
    Rinderknecht E; Humbel RE
    Proc Natl Acad Sci U S A; 1976 Dec; 73(12):4379-81. PubMed ID: 1069990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonsuppressible insulin-like activity in human serum. 3. Differentiation of two distinct molecules with nonsuppressible ILA.
    Jakob A; Hauri C; Froesch ER
    J Clin Invest; 1968 Dec; 47(12):2678-88. PubMed ID: 5725280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The occurrence of a distinct high molecular weight form of serum non-suppressible insulin-like activity.
    Franklin RC; Cameron DP; Burger HG; Herington AC
    Mol Cell Endocrinol; 1979 Nov; 16(2):81-9. PubMed ID: 41788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A bioassay for NSILA-S in individual serum samples and its relationship to somatotropin.
    Franklin RC; Rennie GC; Burger HG; Cameron DP
    J Clin Endocrinol Metab; 1976 Nov; 43(5):1164-9. PubMed ID: 993319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on the possible mechanism for deficiency of nonsuppressible insulin-like activity in thalassemia major.
    Herington AC; Werther GA; Matthews RN; Burger HG
    J Clin Endocrinol Metab; 1981 Mar; 52(3):393-8. PubMed ID: 6257746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of serum nonsuppressible insulin-like activity (NSILA) in compensatory renal growth.
    Poffenbarger PL; Prince MJ
    Growth; 1976 Mar; 40(1):83-97. PubMed ID: 177337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of different extraction procedures on two different molecular weight species of serum NSILA and on the carrier protein of small molecular weight NSILA (NSILA-S).
    Kaufmann U; Zapf J; Froesch ER
    Acta Endocrinol (Copenh); 1979 Apr; 90(4):637-47. PubMed ID: 34963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NSILA-carrier protein abolishes the action of nonsuppressible insulin-like activity (NSILA-S) on perfused rat heart.
    Meuli C; Zapf J; Froesch ER
    Diabetologia; 1978 Apr; 14(4):255-9. PubMed ID: 640301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.